Karl Deres

2.9k total citations · 2 hit papers
16 papers, 2.5k citations indexed

About

Karl Deres is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Karl Deres has authored 16 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Karl Deres's work include Immunotherapy and Immune Responses (6 papers), Hepatitis B Virus Studies (5 papers) and Hepatitis C virus research (5 papers). Karl Deres is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Hepatitis B Virus Studies (5 papers) and Hepatitis C virus research (5 papers). Karl Deres collaborates with scholars based in Germany, Netherlands and Belgium. Karl Deres's co-authors include Hans‐Georg Rammensee, Günther Jung, Hansjörg Schild, Karl‐Heinz Wiesmüller, Kirsten Falk, Olaf Rötzschke, Jörg W. Metzger, G. Jung, Hans Jörg Hacker and Claus H. Schröder and has published in prestigious journals such as Nature, Science and The Journal of Experimental Medicine.

In The Last Decade

Karl Deres

16 papers receiving 2.4k citations

Hit Papers

Isolation and analysis of naturally processed viral pepti... 1989 2026 2001 2013 1990 1989 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Deres Germany 14 1.3k 904 779 510 315 16 2.5k
Brian Livingston United States 31 1.5k 1.1× 880 1.0× 1.5k 1.9× 400 0.8× 481 1.5× 43 2.8k
Ugo D’Oro Italy 31 1.6k 1.2× 722 0.8× 1.1k 1.4× 481 0.9× 359 1.1× 56 2.9k
John Fikes United States 30 1.4k 1.0× 712 0.8× 1.9k 2.4× 480 0.9× 279 0.9× 49 3.3k
Morten A. Nielsen Denmark 36 1.8k 1.4× 359 0.4× 890 1.1× 281 0.6× 231 0.7× 89 4.2k
Glenn Ishioka United States 24 1.5k 1.1× 591 0.7× 844 1.1× 159 0.3× 265 0.8× 45 2.3k
H. S. Marsden United Kingdom 37 864 0.6× 3.0k 3.3× 874 1.1× 353 0.7× 310 1.0× 96 3.8k
Peter Vanlandschoot Belgium 22 804 0.6× 1.1k 1.2× 696 0.9× 268 0.5× 407 1.3× 44 2.1k
Olivier Silvie France 31 820 0.6× 514 0.6× 853 1.1× 153 0.3× 145 0.5× 68 3.0k
Claus H. Schröder Germany 25 247 0.2× 1.5k 1.7× 595 0.8× 909 1.8× 251 0.8× 57 2.1k
Geert‐Jan van Gemert Netherlands 38 1.5k 1.1× 636 0.7× 988 1.3× 152 0.3× 335 1.1× 99 4.7k

Countries citing papers authored by Karl Deres

Since Specialization
Citations

This map shows the geographic impact of Karl Deres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Deres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Deres more than expected).

Fields of papers citing papers by Karl Deres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Deres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Deres. The network helps show where Karl Deres may publish in the future.

Co-authorship network of co-authors of Karl Deres

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Deres. A scholar is included among the top collaborators of Karl Deres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Deres. Karl Deres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Köck, Josef, Michael Nassal, Karl Deres, Hubert E. Blum, & Fritz von Weizsäcker. (2004). Hepatitis B Virus Nucleocapsids Formed by Carboxy-Terminally Mutated Core Proteins Contain Spliced Viral Genomes but Lack Full-Size DNA. Journal of Virology. 78(24). 13812–13818. 82 indexed citations
2.
Deres, Karl, Claus H. Schröder, Siegfried Goldmann, et al.. (2003). Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids. Science. 299(5608). 893–896. 418 indexed citations
3.
Hacker, Hans Jörg, et al.. (2003). Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion. Biochemical Pharmacology. 66(12). 2273–2279. 45 indexed citations
4.
Weber, Olaf, Enno Hartmann, Karl Deres, et al.. (2002). Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Antiviral Research. 54(2). 69–78. 141 indexed citations
5.
Deres, Karl & Helga Rübsamen‐Waigmann. (1999). Development of resistance and perspectives for future therapies against hepatitis B infections: Lessons to be learned from HIV. Infection. 27(S2). S45–S51. 8 indexed citations
6.
Bauer, Petra, et al.. (1998). Ceramide-independent CD28 and TCR signaling but reduced IL-2 secretion in T cells of acid sphingomyelinase-deficient mice. European Journal of Immunology. 28(3). 874–880. 38 indexed citations
8.
Deres, Karl, Werner Beck, Stefan Faath, G. Jung, & Hans‐Georg Rammensee. (1993). MHC/Peptide Binding Studies indicate Hierarchy of Anchor Residues. Cellular Immunology. 151(1). 158–167. 17 indexed citations
9.
Deres, Karl, Ton N. Schumacher, Karl‐Heinz Wiesmüller, et al.. (1992). Preferred size of peptides that bind to H‐2 Kb is sequence dependent. European Journal of Immunology. 22(6). 1603–1608. 40 indexed citations
10.
Schumacher, Ton N., Grada M. van Bleek, Marie-Thérèse Heemels, et al.. (1992). Synthetic peptide libraries in the determination of T cell epitopes and peptide binding specificity of class I molecules. European Journal of Immunology. 22(6). 1405–1412. 29 indexed citations
11.
Wallny, Hans‐Joachim, Karl Deres, Stefan Faath, et al.. (1992). Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. International Immunology. 4(10). 1085–1090. 45 indexed citations
12.
Falk, Kirsten, Olaf Rötzschke, Karl Deres, et al.. (1991). Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.. The Journal of Experimental Medicine. 174(2). 425–434. 216 indexed citations
13.
Schild, Hansjörg, Karl Deres, Karl‐Heinz Wiesmüller, Günther Jung, & Hans‐Georg Rammensee. (1991). Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells. European Journal of Immunology. 21(11). 2649–2654. 121 indexed citations
14.
Schild, Hansjörg, Karl Deres, Kirsten Falk, et al.. (1991). Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide.. The Journal of Experimental Medicine. 174(6). 1665–1668. 62 indexed citations
15.
Rötzschke, Olaf, Kirsten Falk, Karl Deres, et al.. (1990). Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature. 348(6298). 252–254. 657 indexed citations breakdown →
16.
Deres, Karl, Hansjörg Schild, Karl‐Heinz Wiesmüller, Günther Jung, & Hans‐Georg Rammensee. (1989). In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature. 342(6249). 561–564. 549 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026